COMPANY PROFILE
Oxy5 OncoMedical AG
AG (Stock Corporation)DarmstadtManufacture of pharmaceutical preparations
REGISTERED SINCE
2021
Active
TRADE REGISTER
HRB 95641
Düsseldorf
INDUSTRY
Manufacture of pharmaceutical preparations
SIZE CLASS
Micro enterprise
Get an email on insolvency and new register announcements
Key questions answered
What does the company do?
Die Forschung, Entwicklung, Herstellung und Vermarktung von Medikamenten zur Behandlung von Krebserkranungen.
Original text from the German commercial register
Who leads it?
Johannes Coy, Heinz Hänel
How large is it?
Micro enterprise
How stable is it?
Stability assessment in the full profile
Business activity
Industry (WZ2008)
Manufacture of pharmaceutical preparations
WZ C21.20
Size class
Micro
Business purpose
Die Forschung, Entwicklung, Herstellung und Vermarktung von Medikamenten zur Behandlung von Krebserkranungen.
Original text from the German commercial register
Legal essentials
- Register entry
- HRB 95641 (Düsseldorf)
- Legal form
- AG (Stock Corporation)
- Registered since
- 22 Nov 2021
- Share capital
- €76,399
- VAT ID
- —
- Representation rules
- Available in the full profile
Current register extract
The current printout from the commercial register as a PDF: name, seat, purpose, capital, representation and procuration as registered.
Your first 10 documents are included in the free starter credit. After that, 10 Implicents per document, only if retrieved.
Sign up free and downloadAnnual statements
- Balance sheet
- €12,500
- Year
- 2021
2 annual statements are on file for this company.
Annual financial statements (PDF)
The most recently published annual financial statements as a PDF, straight from the German company register.
Included in the free account's starter credit, then 10 Implicents, only if found.
Sign up free and downloadSignals
Four dimensions from hard data — age, financials, register events, compliance. The ratings themselves are in the full profile.
- Continuity1Available in the full profile
- Financials2Available in the full profile
- Management3Available in the full profile
- Legal status4Available in the full profile
Directors & officers
Executive board
Johannes Coy
Board Member
Heinz Hänel
Board Member
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Companies with a similar profile
Emergence Therapeutics GmbH
Duisburg
TOLREMO therapeutics GmbH
Weil am Rhein
Boehringer Ingelheim Biopharmaceuticals GmbH
Ingelheim am Rhein
Location neighbours
No nearby companies found.
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server at mcp.implisense.com — usable with ChatGPT, Claude and your own agents.
Plus opens every profile
Every company profile in full, without spending Implicents on it — plus wider search reach, unlimited lists and the enriched export.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- The full commercial register history — on every profile
- Full search reach instead of the first page of hits
- Enriched Excel export (Plus only)